Rancho Santa Fe, CA, United States of America

Jan Tuttleman

This inventor holds 1 USPTO granted patent. Top assignee: Chiron Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Tuttleman. Retrieved from https://idiyas.com/inventor/jan-tuttleman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Tuttleman: Innovator in Recombinant Proteins

Introduction

Jan Tuttleman is a notable inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of biochemistry, particularly in the development of recombinant proteins. His work has implications for medical research and therapeutic applications.

Latest Patents

Jan Tuttleman holds a patent titled "Recombinant PR-3 and assays employing the same." This patent discloses methods and materials for producing purified, active recombinant human neutrophil protease, PR-3, through the activation of a pro-form known as proPR-3. Human PR-3 is valuable for discovering inhibitors of excessive release of mature, active TNFα. The patent also outlines methods for identifying inhibitors that convert the pro-form of TNFα to its mature active form. He has 1 patent to his name.

Career Highlights

Tuttleman has worked with Chiron Corporation, a company known for its innovative approaches in biotechnology. His role at Chiron has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Jan Tuttleman has collaborated with esteemed colleagues, including Robert F. Halenbeck and Michael Kriegler. These collaborations have furthered advancements in their shared field of expertise.

Conclusion

Jan Tuttleman is a distinguished inventor whose work in recombinant proteins has the potential to impact medical research significantly. His contributions continue to pave the way for future innovations in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…